Opinion summary
Etalia.ai summary of the majority opinion
The case addressed the regulatory authority of the Secretary of Health, Education, and Welfare under the Federal Food, Drug, and Cosmetic Act. Hynson, Westcott & Dunning challenged regulations requiring drug manufacturers to prove their products' effectiveness before marketing them. The Supreme Court upheld these requirements as a valid exercise of administrative power aimed at protecting public health by ensuring that marketed drugs are both safe and effective. The decision reinforced the government's role in overseeing pharmaceutical standards to prevent ineffective or potentially harmful medications from reaching consumers.
Opinion written by Justice Douglas
Decided 18 Jun 1973 · Official report